Barclays’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$362M Buy
2,834,160
+943,752
+50% +$118M 0.13% 166
2025
Q4
$230M Sell
1,890,408
-113,939
-6% -$13.1M 0.09% 257
2025
Q3
$201M Buy
2,004,347
+1,487,139
+288% +$134M 0.07% 295
2025
Q2
$42.9M Buy
517,208
+351,361
+212% +$28M 0.02% 776
2025
Q1
$13.5M Sell
165,847
-222,542
-57% -$19.9M 0.01% 1225
2024
Q4
$35M Sell
388,389
-134,181
-26% -$13M 0.02% 814
2024
Q3
$51.6M Sell
522,570
-145,673
-22% -$14.3M 0.02% 657
2024
Q2
$62M Buy
668,243
+243,176
+57% +$21.8M 0.03% 552
2024
Q1
$40.3M Sell
425,067
-248,643
-37% -$23.1M 0.02% 695
2023
Q4
$60.2M Sell
673,710
-397,740
-37% -$29.5M 0.03% 586
2023
Q3
$78.2M Sell
1,071,450
-179,635
-14% -$14.3M 0.05% 372
2023
Q2
$104M Sell
1,251,085
-2,874,672
-70% -$240M 0.07% 264
2023
Q1
$314M Buy
4,125,757
+3,420,718
+485% +$284M 0.33% 83
2022
Q4
$58.5M Sell
705,039
-678,544
-49% -$54.9M 0.05% 428
2022
Q3
$110M Buy
1,383,583
+434,845
+46% +$36.7M 0.12% 163
2022
Q2
$70.5M Sell
948,738
-503,902
-35% -$37.8M 0.08% 292
2022
Q1
$131M Sell
1,452,640
-485,399
-25% -$44.8M 0.11% 193
2021
Q4
$217M Buy
1,938,039
+63,916
+3% +$7.71M 0.13% 202
2021
Q3
$236M Sell
1,874,123
-41,992
-2% -$5.41M 0.17% 152
2021
Q2
$259M Buy
1,916,115
+46,309
+2% +$6.09M 0.21% 132
2021
Q1
$254M Sell
1,869,806
-765,404
-29% -$115M 0.24% 114
2020
Q4
$371M Sell
2,635,210
-1,854,963
-41% -$238M 0.41% 74
2020
Q3
$500M Sell
4,490,173
-610,052
-12% -$68.4M 0.59% 52
2020
Q2
$571M Sell
5,100,225
-583,531
-10% -$57.5M 0.93% 31
2020
Q1
$440M Buy
5,683,756
+1,946,868
+52% +$172M 0.72% 48
2019
Q4
$355M Buy
3,736,888
+829,050
+29% +$71.7M 0.39% 81
2019
Q3
$222M Buy
2,907,838
+386,747
+15% +$32.1M 0.28% 117
2019
Q2
$221M Buy
2,521,091
+190,071
+8% +$16.2M 0.25% 119
2019
Q1
$211M Buy
2,331,020
+1,600,643
+219% +$136M 0.3% 102
2018
Q4
$52.4M Buy
730,377
+12,593
+2% +$1.01M 0.09% 363
2018
Q3
$68.8M Buy
717,784
+20,065
+3% +$1.95M 0.1% 302
2018
Q2
$66.4M Sell
697,719
-100,702
-13% -$9.26M 0.12% 282
2018
Q1
$70M Sell
798,421
-27,638
-3% -$2.52M 0.1% 308
2017
Q4
$70.1M Buy
826,059
+595,091
+258% +$49.9M 0.11% 284
2017
Q3
$20M Sell
230,968
-247,166
-52% -$19.8M 0.05% 670
2017
Q2
$36.9M Sell
478,134
-72,788
-13% -$5.16M 0.08% 374
2017
Q1
$38.2M Sell
550,922
-58,596
-10% -$3.94M 0.09% 328
2016
Q4
$36.1M Sell
609,518
-672,357
-52% -$41.5M 0.11% 360
2016
Q3
$85M Buy
1,281,875
+612,124
+91% +$37.9M 0.28% 160
2016
Q2
$36.2M Sell
669,751
-280,060
-29% -$15.3M 0.12% 327
2016
Q1
$48.4M Buy
949,811
+177,300
+23% +$9.21M 0.16% 227
2015
Q4
$54.1M Sell
772,511
-31,401
-4% -$2.14M 0.16% 255
2015
Q3
$49.8M Sell
803,912
-98,878
-11% -$7.79M 0.13% 280
2015
Q2
$75.8M Buy
902,790
+173,391
+24% +$13.5M 0.18% 198
2015
Q1
$54.7M Sell
729,399
-20,388
-3% -$1.42M 0.12% 299
2014
Q4
$46.5M Sell
749,787
-9,900
-1% -$564K 0.08% 382
2014
Q3
$39.3M Sell
759,687
-45,588
-6% -$2.32M 0.07% 411
2014
Q2
$41.1M Buy
805,275
+302,787
+60% +$13.7M 0.08% 381
2014
Q1
$23.8M Sell
502,488
-336,561
-40% -$17.2M 0.05% 597
2013
Q4
$36.4M Buy
839,049
+388,275
+86% +$16.1M 0.07% 463
2013
Q3
$19.4M Buy
450,774
+300,414
+200% +$12.2M 0.05% 691
2013
Q2
$5.23M Buy
+150,360
New +$5.28M 0.01% 1592

Other funds holding XBI